Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Healthtrust
Cipla
Mallinckrodt
Queensland Health
Farmers Insurance
Johnson and Johnson
Boehringer Ingelheim
Express Scripts
Fuji

Generated: January 17, 2018

DrugPatentWatch Database Preview

OLOPATADINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Olopatadine Hydrochloride, and what generic alternatives are available?

Olopatadine Hydrochloride is a drug marketed by Akorn Inc, Apotex Inc, Aurobindo Pharma Ltd, Barr Labs Inc, Cipla Ltd, Somerset Theraps Llc, Usv North America, Wockhardt Ltd, Zambon Spa, and Perrigo Israel. and is included in eleven NDAs.

The generic ingredient in OLOPATADINE HYDROCHLORIDE is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Eighteen suppliers are listed for this compound. There are five tentative approvals for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Drug patent expirations by year for OLOPATADINE HYDROCHLORIDE
Pharmacology for OLOPATADINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for OLOPATADINE HYDROCHLORIDE

US Patents and Regulatory Information for OLOPATADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 204532-001 Jan 10, 2017 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usv North America OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 203152-001 Dec 7, 2015 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr Labs Inc OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 090848-001 Jul 13, 2015 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt Ltd OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 200810-001 Jun 28, 2017 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 078350-001 Dec 7, 2015 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 204812-001 Dec 18, 2015 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Somerset Theraps Llc OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 206306-001 Dec 7, 2015 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cipla Ltd OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 206046-001 Jul 26, 2017 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SPRAY, METERED;NASAL 091572-001 Oct 8, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo Israel OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SPRAY, METERED;NASAL 202853-001 Jan 31, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Express Scripts
Dow
Johnson and Johnson
Covington
Fish and Richardson
Boehringer Ingelheim
Argus Health
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot